360 Participants Needed

Guidewire IV Catheters for Catheter Survival

AB
DB
MC
Overseen ByMaureen Cooney, RN
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: William Beaumont Hospitals
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Guidewire-assisted intravenous catheter insertion?

Research shows that using a guidewire with peripheral venous catheters leads to higher success rates and satisfaction in patients with difficult venous access. Additionally, a modified guidewire technique was found to be faster than traditional methods in a study with novice operators.12345

Is guidewire-assisted intravenous catheter insertion generally safe for humans?

Guidewire-assisted catheter insertion is generally safe, but there are rare risks such as guidewire retention (when the wire is accidentally left inside the body) and arrhythmias (irregular heartbeats) during the procedure. These risks can be minimized with proper training and safety measures.678910

How is guidewire-assisted intravenous catheter insertion different from other treatments?

Guidewire-assisted intravenous catheter insertion is unique because it uses a guidewire to help place the catheter more accurately and safely, reducing the risk of complications like catheter misplacement or breakage. This method can improve the success rate of catheter placement compared to traditional techniques.2451011

What is the purpose of this trial?

This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.

Research Team

AB

Amit Bahl, MD

Principal Investigator

William Beaumont Hospitals

Eligibility Criteria

This trial is for clinicians at Corewell Health William Beaumont University Hospital who are trained in vascular access and patients over 18 with a specific Vascular Access Score. Patients must be able to give consent, have no cognitive impairments, skin issues at the IV site, or limited elbow mobility.

Inclusion Criteria

I am 18 or older with a high need for vascular access.
Clinician must work in the emergency department at Corewell Health William Beaumont University Hospital (physician, advanced practice provider, nurse, technician)
My doctor is trained in using Operation STICK for vascular access.

Exclusion Criteria

I do not have any cognitive impairments.
I can move my elbow joint freely.
My skin is clear for IV access.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive either the control ultralong intravenous catheter or the experimental catheter with guide wire. Data regarding placement, technique, and clinician experience are collected.

up to 15 days
Daily follow-ups

Follow-up

Participants are monitored for catheter functionality, complications, and thrombosis development up to 30 days post discharge.

up to 30 days post discharge

Treatment Details

Interventions

  • Guidewire-assisted intravenous catheter insertion
Trial Overview The study compares two types of intravenous catheters: one standard ultralong catheter and another with a built-in guide wire. Participants will be randomly assigned to either group to see if the guide wire improves catheter longevity without increasing complications.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm 2 (5.71 cm 20 gauge Accucath)Experimental Treatment1 Intervention
Arm 2 Device: BD 5.71 cm 20 gauge Accucath, ultralong intravenous catheter with guide wire
Group II: Arm 1 (6.35cm 20 gauge ultralong intravenous catheter)Active Control1 Intervention
Arm 1 Device: B. Braun 6.35cm 20 gauge ultralong intravenous catheter

Find a Clinic Near You

Who Is Running the Clinical Trial?

William Beaumont Hospitals

Lead Sponsor

Trials
153
Recruited
113,000+

Findings from Research

The guide wire-associated peripheral venous catheter (GAPIV) achieved an 85% first attempt success rate in patients with difficult venous access, compared to only 22% for traditional catheters, indicating a significant improvement in efficacy.
Patient satisfaction scores were notably higher for the GAPIV, with a median score of 5 compared to 2 for traditional catheters, and physician satisfaction also favored the GAPIV due to its ease of use and efficiency.
Higher success rates and satisfaction in difficult venous access patients with a guide wire-associated peripheral venous catheter.Chiricolo, G., Balk, A., Raio, C., et al.[2019]
The guidewire-assisted technique for IV cannula placement was taught to 24 novice operators and demonstrated a 22% faster performance compared to the classic cutdown method, averaging two minutes and 13 seconds quicker (P < 0.05).
This modified technique not only improves speed but may also offer additional advantages, making it a potentially safer and more efficient option for IV cannulation.
A modified wire-guided technique for venous cutdown access.Shockley, LW., Butzier, DJ.[2019]
In a pilot study involving 70 patients with difficult intravenous access, the use of a guidewire during ultrasound-guided peripheral IV placement did not significantly improve the first-pass success rate compared to placement without a guidewire, with rates of 47.1% and 45.7% respectively.
There were no significant differences in the number of attempts, complication rates, or clinician-reported ease of insertion between the two methods, suggesting that the guidewire may not provide additional benefits in this context.
A randomized trial of ultrasound-guided peripheral IV catheter placement in difficult access patients using a guidewire approach.Cochrane, HK., Henwood, PC., Platz, E., et al.[2020]

References

Higher success rates and satisfaction in difficult venous access patients with a guide wire-associated peripheral venous catheter. [2019]
A modified wire-guided technique for venous cutdown access. [2019]
A randomized trial of ultrasound-guided peripheral IV catheter placement in difficult access patients using a guidewire approach. [2020]
Intertwining and knotting of a guidewire with a central venous catheter. [2019]
A new guidewire technique for difficult cardiac catheterization. [2017]
Central Venous Catheter Guidewire Retention: Lessons From England's Never Event Database. [2023]
WireSafeTM - A pilot study of a novel safety engineered device designed to prevent guidewire retention and reduce sharps injuries during central venous catheter insertion. [2023]
Randomized comparison of three guidewire insertion depths on incidence of arrhythmia during central venous catheterization. [2017]
Special article: retained guidewires after intraoperative placement of central venous catheters. [2013]
Guidewire-Assisted Reduction Technology Combined with Postural Reduction Improves the Success Rate of Internal Vein Catheterisation. [2022]
Development of a safe guidewire. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security